Detection of BCR-ABL positive cells in an asymptomatic patient: A case report and literature review

Case Reports in Medicine

Volumn 2010, Issue , 2010, Pages

  Bayraktar, Soley ^a   Goodman, Mark ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992361009     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2010/939706     Document Type: Article

References (12)

1. A. Redaelli, C. F. Bell, J. Casagrande, et al., "Clinical and epidemiologic burden of chronic myelogenous leukemia," Expert Review of Anticancer Therapy, vol. 4, no. 1, pp. 85-96, 2004. (Pubitemid 38208489)
2. P. C. Nowell and D. A. Hungerford, "Chromosome studies in human leukemia. II. Chronic granulocytic leukemia," Journal of the National Cancer Institute, vol. 27, pp. 1013-1035, 1961.
3. B. J. Druker, F. Guilhot, S. G. O'Brien, et al., "Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia," The New England Journal of Medicine, vol. 355, no. 23, pp. 2408-2417, 2006. (Pubitemid 44903745)
4. L. Selleri, G. Emilia, M. Luppi, et al., "Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative"," Hematologic Pathology, vol. 4, no. 2, pp. 67-77, 1990. (Pubitemid 20193503)
5. S. Bose, M. Deininger, J. Gora-Tybor, J. M. Goldman, and J. V. Melo, "The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease," Blood, vol. 92, no. 9, pp. 3362-3367, 1998. (Pubitemid 28492345)
6. C. Biernaux, M. Loos, A. Sels, G. Huez, and P. Stryckmans, "Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals," Blood, vol. 86, no. 8, pp. 3118-3122, 1995.
7. J. Bäsecke, F. Griesinger, L. Trümper, and G. Brittinger, "Leukemia- and lymphoma-associated genetic aberrations in healthy individuals," Annals of Hematology, vol. 81, no. 2, pp. 64-75, 2002. (Pubitemid 36067578)
8. C. L. Sawyers, "Chronic myeloid leukemia," The New England Journal of Medicine, vol. 340, no. 17, pp. 1330-1340, 1999.
9. J. M. Goldman and J. V. Melo, "Mechanisms of disease: chronic myeloid leukemia - advances in biology and new approaches to treatment," The New England Journal of Medicine, vol. 349, no. 15, pp. 1451-1464, 2003.
10. M. Yanagi, K. Shinjo, A. Takeshita, et al., "Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells," Leukemia, vol. 13, no. 4, pp. 542-552, 1999. (Pubitemid 29195282)
11. T. Hughes, M. Deininger, A. Hochhaus, et al., "Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results," Blood, vol. 108, no. 1, pp. 28-37, 2006. (Pubitemid 43990609)
12. B. J. Druker, M. Talpaz, D. J. Resta, et al., "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia," The New England Journal of Medicine, vol. 344, no. 14, pp. 1031-1037, 2001. (Pubitemid 32267972)